Head and Neck Cancer Trial, Recruiting NCT06127784 Sponsor: Western University, Canada Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06127784
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who are willing to give their formal consent to participate
  • People who have been diagnosed with stage I to IVA head and neck mucosal cancer (in areas such as the voice box, throat, mouth, or nasal passages)
  • People whose last major cancer treatment (such as surgery, chemotherapy, or radiation) was completed between 3 and 6 months before joining the trial
  • People who can speak, read, and write in English

Who may not be able to join:

  • People who have a second active cancer (other than skin cancer) at the same time
  • People whose cancer has spread to other parts of the body
  • People who have noticeable difficulties with thinking, memory, or understanding
  • People where there are concerns that cancer may still be present after treatment has finished

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Danielle MacNeil, MD, FRCSC, Department of Otolaryngology-Head & Neck Surgery, Western University Canada

Phone: 519-685-8500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Western University, Canada
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
1 January 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Physician implementation of survivorship care recommendations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov